A team of Geisinger researchers has identified a common genetic variant as a risk factor for stroke, especially in patients older than 65. Cerebral small vessel disease (SVD) causes about a quarter of ischemic strokes worldwide and is the most common cause of vascular dementia. SVD can manifest as lesions…
Inferring human genomes at a fraction of the cost promises to boost biomedical research
Thousands of genetic markers have already been robustly associated with complex human traits, such as Alzheimer’s disease, cancer, obesity, or height. To discover these associations, researchers need to compare the genomes of many individuals at millions of genetic locations or markers, and therefore require cost-effective genotyping technologies. A new statistical…
Covid-19 virus can cause blood-brain barrier, says new study
A new study by University of Washington Health Sciences/UW Medicine strongly claims that Covid-19 virus can show cognitive effects to the patients such as brain fog and fatigue. The study published in Nature Neuroscience shows that the SARS-CoV-2, the cause of Covid-19, can enter the brain. Researchers, through a mouse…
Research finds promising treatment to protect kidney function in diabetes
A clinical trial involving researchers at University of Limerick, Ireland has demonstrated the potential benefits of new drugs in protecting kidney function in diabetes. The new study has found that combining two treatments that lower uric acid concentrations in the blood reduces the leakage of albumin in the urine, one…
Connection between COVID-19 and loss of smell uncovered by research team
About 70% of people with COVID-19 suddenly lose their sense of smell, although fewer of them seem to realize it, according to a new “living analysis” by a research team. Vicente Ramirez, a Ph.D. student in UC Merced’s Public Health program, and researchers at the Monell Chemical Senses Center in…
Study suggests an acebuchin-oil-enriched diet helps to reduce hypertension
An acebuchin-oil-enriched diet helps to reduce arterial blood pressure, as shown by a study carried out by the Cardiovascular Physiopathology research group at the Physiology Department of the University of Seville. Furthermore, their work shows that acebuche oil has a greater impact in reducing hypertension than extra virgin olive oil….
Treatments for people with early COVID-19 infection is an urgent research focus
COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their…
Research shows potential of artificial intelligence to screen for cardiovascular disease
A rapidly growing body of evidence suggests the microscopic bacteria that live in our digestive tracts have a profound effect on our cardiovascular health. With the assistance of artificial intelligence, University of Toledo scientists have shown it might be possible to use those microorganisms to diagnose heart and vascular diseases…
Research identifies sperm biomarker associated with couples’ pregnancy probability
Researchers at the University of Massachusetts Amherst have identified a single-measure biomarker in sperm mitochondrial DNA that may predict male reproductive health and pregnancy success. The discovery applies not just to couples seeking care for infertility but also for the general population. This biomarker could become a more accurate predictor…
Research helps pave way for newly approved use of drug
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a…
United States COVID-19 transmission driven by ages 20-49, research finds
Resurging COVID-19 transmission in the US is being driven by ages 20-49 and targeted measures are needed to control the epidemic as schools re-open. An estimated two in three COVID-19 cases came from adults aged 20-49 according to a new report by the Imperial College London COVID-19 Response Team, the…